Ivrc 2002
Research payments
$1,222,608
Through program year 2020, $1,222,608 in research payments was reported against Ivrc 2002, across 131 payments, paid by Taro Pharmaceuticals USA, Inc..
- Paid by
- Taro Pharmaceuticals USA, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $1,222,608 | 131 |
Breakdown
Usually the institution or organisation running the study, not a person.
Only reported on some payments, and a payment can report more than one category, so these amounts overlap.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Aldo Maspons El Paso, TX Named on 21 payments
- James Moretti Pittsburgh, PA Named on 17 payments
- George Monlux Palm Coast, FL Named on 11 payments
- Francisco Badar Cerritos, CA Named on 9 payments
- Igor Chaplik Ft Lauderdale, FL Named on 8 payments
- Jawahar Sundaram Los Angeles, CA Named on 8 payments
- Robert Haber Beachwood, OH Named on 7 payments
- Sarah Jackson New Orleans, LA Named on 7 payments
- David Fried East Greenwich, RI Named on 6 payments
- Hector Wiltz Jr Miami, FL Named on 6 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.